USPTO Examiner AVIGAN ADAM JOSEPH - Art Unit 3794

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17092321AIR FLOW SYSTEM WITH A PROXIMAL CONNECTOR AND A FLOW CHAMBERNovember 2020July 2024Allow4400NoNo
17087813TREATMENT SYSTEM FOR CANCER etcNovember 2020February 2022Allow1530YesNo
17081347DAMAGING CANCEROUS CELLS UTILIZING RADIO FREQUENCY WAVES IN HEATING WITH HEATING ENHANCED BY INFUSION OR INJECTION OF GLUCOSEOctober 2020January 2025Abandon5110NoNo
17036269HAND-HELD CRYOTHERAPY DEVICE INCLUDING CRYOGEN TEMPERATURE CONTROLLER AND METHOD THEREOFSeptember 2020June 2021Allow920NoNo
17004384High Efficiency Heat Exchange Catheters for Control of Patient Body TemperatureAugust 2020June 2025Abandon5821NoNo
16996308PROCESS UTILIZING PULSED ENERGY TO HEAT TREAT BIOLOGICAL TISSUEAugust 2020April 2021Allow811NoNo
16984486SYSTEM AND METHOD FOR PREVENTING OR TREATING ALZHEIMER'S AND OTHER NEURODEGENERATIVE DISEASESAugust 2020November 2020Allow410NoNo
16945789COOLING CUP APPLICATORS WITH CONTOURED HEADS AND LINER ASSEMBLIESJuly 2020December 2024Abandon5210NoNo
16931849PHYSICAL TARGETED HYPERTHERMIA SYSTEM USED FOR TUMOR THERAPY AND CONTROL METHOD THEREOFJuly 2020October 2024Abandon5110NoNo
16917998NEEDLE WARMING SYSTEMJuly 2020September 2024Abandon5110NoNo
16891781METHODS AND APPARATUSES FOR MANIPULATING TEMPERATUREJune 2020September 2024Allow5260YesNo
16888842HEATING / COOLING BODY TREATMENT THERAPY PAD SYSTEMMay 2020May 2021Allow1110NoNo
16857699Method and System for Treatment of User's EarApril 2020May 2022Abandon2530NoYes
16741959SYSTEM, METHOD, AND COMPUTER PROGRAM FOR PROVIDING TRAINING FOR PAIN IMPROVEMENTJanuary 2020October 2020Allow920NoNo
16742188TEMPERATURE PROVIDING DEVICEJanuary 2020March 2021Allow1410NoNo
16738532WIDE BAND MICROWAVE TISSUE ABLATION PROBE WITH VARIABLE LENGTH ANTENNA PARAMETERSJanuary 2020March 2022Allow2610NoNo
16731523Detecting and Responding to PreshiveringDecember 2019November 2024Allow5920NoNo
16679722Scalp Cooling Apparatus, Method, and SystemNovember 2019January 2021Allow1411NoNo
16660340System for Treatment of Eye ConditionsOctober 2019December 2023Allow5010NoNo
16660526FLEXIBLE THERMAL DEVICEOctober 2019January 2024Abandon5110NoNo
16587654MULTIPLE ELECTRODE RADIOFREQUENCY GENERATORSeptember 2019September 2024Abandon6030NoNo
16531871DEFORMABLE THERMAL PACKAugust 2019November 2023Abandon5122YesNo
16482581DEVICES FOR DUAL MECHANISM AESTHETIC TREATMENT AND METHODS OF USE THEREOFJuly 2019February 2025Abandon6031NoNo
16524359SYSTEM FOR INDUCING DESIRABLE TEMPERATURE EFFECTS ON BODY TISSUEJuly 2019August 2024Allow6040NoNo
16478839SYSTEMS AND METHODS FOR THERMAL TREATMENT OF TISSUEJuly 2019April 2025Allow6011NoNo
16508902SHORT WAVE VISUALIZATION PROBE DEVICEJuly 2019September 2023Abandon5110NoNo
16508005METHOD AND APPARATUS FOR THERAPEUTIC HYPERTHERMIA DURING AN MRI SCANJuly 2019September 2023Abandon5010NoNo
16452943Heating/Cooling Therapy SystemJune 2019December 2022Abandon4210NoNo
16473325PORTABLE COOLING DEVICE FOR HUMANS AND/OR ANIMALSJune 2019September 2023Abandon5120NoNo
16433465DEVICES AND METHODS FOR WEARABLESJune 2019November 2023Abandon5361YesNo
16425557POLYMERS, THERMOCHROMIC AGENTS, AND/OR HYDROGEL COMPOSITIONS AND APPARATUS, INCLUDING PRODUCTS EMBODYING THE SAME, AND METHODS AND PROCESSES FOR MAKING SAMEMay 2019February 2023Allow4520NoNo
16397015CRYOTHERAPY, THERMAL THERAPY, TEMPERATURE MODULATION THERAPY, AND PROBE APPARATUS THEREFORApril 2019January 2023Allow4520NoNo
16376956DEVICES, SYSTEMS AND METHODS FOR TREATING THE SKINApril 2019March 2023Allow4750NoNo
16365567HEAT EXCHANGE MODULE, SYSTEM AND METHODMarch 2019June 2022Allow3810NoNo
16333392METHODS AND SYSTEMS OF INDUCING HYPERTHERMIA IN CANCER CELLSMarch 2019December 2022Abandon4520NoNo
16332630DEVICE FOR LOCALIZED COOLING OF AN ORGANMarch 2019July 2022Allow4000NoNo
16273764PORTABLE NON-INVASIVE DEVICES FOR INTEGRATIVE MEDICINE AND HOLISTIC HEALINGFebruary 2019August 2022Abandon4270YesNo
16244498Simultaneous Thermal and Cooling Therapeutic DeviceJanuary 2019August 2021Abandon3160NoNo
16238305Temperature Changing BlanketsJanuary 2019April 2023Allow5221YesNo
16238374SYSTEMS AND METHODS FOR IMPLANTABLE DEVICESJanuary 2019June 2023Allow5411NoNo
16207923THERMAL CONTRAST THERAPY SYSTEMS, DEVICES, AND METHODSDecember 2018May 2023Abandon5310NoNo
16181851DRY EYE TREATMENT DEVICENovember 2018January 2021Abandon2710NoNo
16176838METHOD OF REGULATING BODY TEMPERATUREOctober 2018February 2019Allow400NoNo
16134258CEREBRAL PROTECTION SYSTEMSeptember 2018February 2022Allow4110NoNo
16124601METHOD AND SYSTEM FOR CONTROL OF A PATIENT'S BODY TEMPERATURE BY WAY OF A TRASLUMINALLY INSERTABLE HEAT EXCHANGE CATHETERSeptember 2018November 2021Abandon3810NoNo
16125606SYSTEMS, DEVICES AND METHODS THAT AFFECT NEURAL TISSUE THROUGH THE DELIVERY OF A PULSED RADIO FREQUENCY SIGNAL GENERATED BY AN IMPLANTABLE MEDICAL DEVICESeptember 2018February 2022Abandon4110NoNo
16116316Heating/Cooling Therapy SystemAugust 2018April 2019Allow710YesNo
16102935ENERGY DELIVERY DEVICES AND METHODSAugust 2018April 2022Abandon4420NoNo
16051690PATIENT TEMPERATURE CONTROL CATHETER WITH HELICAL HEAT EXCHANGE PATHSAugust 2018July 2024Allow6051YesNo
16041183DEVICES, SYSTEMS, AND METHODS FOR CONTROLLING TEMPERATURE IN PEDIATRIC SUBJECTSJuly 2018November 2021Abandon4020NoNo
16039779SYSTEM AND PROCESS OF UTILIZING ENERGY FOR TREATING BIOLOGICAL TISSUEJuly 2018June 2021Allow3511NoNo
16038561PROCESS AND SYSTEM FOR UTILIZING ENERGY TO TREAT BIOLOGICAL TISSUEJuly 2018January 2020Allow1840NoNo
16026427WORKING FLUID CASSETTE WITH HINGED PLENUM OR ENCLOSURE FOR INTERFACING HEAT EXCHANGER WITH INTRAVASCULAR TEMPERATURE MANAGEMENT CATHETERJuly 2018June 2023Allow5940YesNo
16022396SYSTEM FOR CONTROLLING ACTIVATION OF MULTIPLE APPLICATORS FOR TISSUE TREATMENTJune 2018January 2022Abandon4320NoNo
16065993DEVICE FOR TREATING A SURFACE WITH A DIELECTRIC BARRIER PLASMAJune 2018March 2021Allow3310NoNo
16014147THERMAL THERAPY DEVICE FOR PROVIDING CONTROLLED HEATING AND COOLING VIA AN APPLIED TISSUE INTERACTING DEVICEJune 2018August 2021Abandon3810NoNo
16063964INFRARED SUDATION DEVICEJune 2018November 2021Allow4120NoNo
16009738HYPERTHERMIA, SYSTEM, METHOD AND COMPONENTSJune 2018August 2023Abandon6030YesYes
16001873METHODS AND APPARATUSES FOR THE THERMAL TREATMENT OF NEUROLOGIC AND PSYCHIATRIC DISORDERSJune 2018August 2021Abandon3810NoNo
15997186THERMOREGULATORY GLOVE AND METHOD FOR PRODUCING A CONVERGENCE IN BODY TEMPERATUREJune 2018April 2021Abandon3410NoNo
15996973COOLING GARMENTS, WARMING GARMENTS, AND RELATED METHODSJune 2018January 2023Allow5640NoNo
15780748Device and Method for Nerve Block by Local Cooling to Room TemperatureJune 2018February 2021Allow3310YesNo
15985740DEVICE, SYSTEM AND METHOD FOR SAFE RADIO FREQUENCY TREATMENTMay 2018April 2023Abandon5940YesNo
15986790Polymers, Thermochromic Agents, And/Or Hydrogel Compositions And Apparatus, Including Products Embodying The Same, And Methods And Processes For Making SameMay 2018July 2019Allow1411NoNo
15956218Method and apparatus that use the spectral reflectance characteristics of a reflector matrix, or other spectral filters, to limit available broad spectrum electromagnetic energy, reflected toward a patient target, to specific infrared bandwidths, to increase the effectiveness, comfort and/or duration of thermotherapyApril 2018February 2021Abandon3410NoNo
15764850AIR FLOW SYSTEM AND METHOD FOR AIR CIRCULATION THERAPYMarch 2018August 2020Allow2800NoNo
15936860THERMAL SYSTEMMarch 2018January 2021Allow3410NoNo
15927937TEMPERATURE AND FLOW CONTROL METHODS IN A THERMAL THERAPY DEVICEMarch 2018April 2021Abandon3701NoNo
15918487PROCESS UTILIZING PULSED ENERGY TO HEAT TREAT BIOLOGICAL TISSUEMarch 2018July 2020Allow2951NoNo
15902457THERAPEUTIC DEVICE FOR HEATING AND ICING BODY PARTSFebruary 2018December 2020Allow3310YesNo
15891700NEURON INHIBITION BY INFRARED LIGHTFebruary 2018August 2021Abandon4220NoNo
15890142APPARATUS FOR PROVIDING A HEATING OR COOLING EFFECTFebruary 2018December 2020Abandon3410NoNo
15885653DEVICES FOR DUAL MECHANISM AESTHETIC TREATMENT AND METHODS OF USE THEREOFJanuary 2018July 2019Abandon1820YesNo
15885329METHOD FOR IMPROVEMENT OF CELLULITE APPEARANCEJanuary 2018November 2022Abandon5840NoNo
15877583COOLED MEDICAL HANDPIECEJanuary 2018July 2022Abandon5440YesNo
15746023DEVICE FOR RADIO-FREQUENCY SKIN TREATMENTJanuary 2018January 2022Allow4831YesNo
15859420Portable Heat Generating BandageDecember 2017November 2020Allow3410NoNo
15852293PHASE-CHANGE NANOPARTICLEDecember 2017September 2018Allow810NoNo
15844581Multi-frequency Microwave Acupuncture and Moxibustion Apparatus and its Method for Treating Knee OsteoarthritisDecember 2017September 2020Abandon3310NoNo
15840127SUPPORT APPARATUSES COMPRISING COOLING ELEMENTSDecember 2017December 2020Allow3630YesNo
15828273CARDIAC HEALTH MONITORING SYSTEMS AND METHODS INVOLVING HYPERTENSION RELIEF DEVICE(S) AND/OR FEATURESNovember 2017May 2021Abandon4220NoNo
15824967METHODS AND DEVICES FOR TREATING HPV-ASSOCIATED LESIONS USING NANOSECOND PULSED ELECTRIC FIELDSNovember 2017March 2022Abandon5140YesYes
15573006Method to Improve Neurologic Outcomes in Temperature Managed PatientsNovember 2017December 2022Allow6050YesNo
15806521POWER-STAGE ANTENNA INTEGRATED SYSTEM WITH HIGH-STRENGTH SHAFTNovember 2017October 2020Abandon3510NoNo
15568924DEVICE FOR RADIO FREQUENCY SKIN TREATMENTOctober 2017January 2021Allow3920YesNo
15568664CORE BODY TEMPERATURE MANAGEMENT OF AN ANESTHETIZED PATIENTOctober 2017October 2020Abandon3610NoNo
15567898MOXIBUSTION DEVICE, METHOD AND SYSTEM FOR CONTROLLING SAMEOctober 2017February 2021Abandon4020NoNo
15786634Assessing Temperature Tolerance of Eyelids for Treating Meibomian Gland Dysfunction (MGD) and Dry EyeOctober 2017January 2021Abandon3920NoNo
15782184ENERGY DELIVERY DEVICES AND METHODSOctober 2017March 2021Abandon4120YesNo
15729174Thermoregulating GelpackOctober 2017October 2020Allow3720NoNo
15727554SYSTEMS, DEVICES AND METHODS THAT AFFECT NEURAL TISSUE THROUGH THE DELIVERY OF A PULSED RADIO FREQUENCY SIGNAL GENERATED BY AN IMPLANTABLE MEDICAL DEVICEOctober 2017July 2018Allow910NoNo
15564350MEDICAL COOLING DEVICE AND METHOD FOR COOLING INFUSION FLUIDSOctober 2017August 2020Abandon3410NoNo
15563982NON-INVASIVE SKIN TREATMENT DEVICE USING R.F. ELECTRICAL CURRENT WITH A TREATMENT SETTINGS DETERMINEROctober 2017July 2021Allow4640NoNo
15562816EXOTHERMIC DEVICESeptember 2017July 2020Abandon3310NoNo
15710192PEEL AND STICK HEATING PAD FOR BREASTSeptember 2017August 2020Abandon3510NoNo
15703958Instrument for regulating vital energy zen qiSeptember 2017December 2020Abandon3920NoNo
15557024MOXIBUSTION DEVICESeptember 2017February 2020Allow2920NoNo
15695642MONOPOLAR ELECTROSURGERY BLADE AND ELECTROSURGERY BLADE ASSEMBLYSeptember 2017January 2025Abandon6040NoYes
15692342END EFFECTOR FOR ELECTROSURGICAL INSTRUMENT WITH IRRIGATIONAugust 2017March 2022Allow5521YesYes
15689773CONTROL OF SURGICAL FIELD IRRIGATION BY ELECTROSURGICAL TOOLAugust 2017February 2020Allow2910YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner AVIGAN, ADAM JOSEPH.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
10
Examiner Affirmed
7
(70.0%)
Examiner Reversed
3
(30.0%)
Reversal Percentile
48.1%
Lower than average

What This Means

With a 30.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
26
Allowed After Appeal Filing
4
(15.4%)
Not Allowed After Appeal Filing
22
(84.6%)
Filing Benefit Percentile
19.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 15.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner AVIGAN, ADAM JOSEPH - Prosecution Strategy Guide

Executive Summary

Examiner AVIGAN, ADAM JOSEPH works in Art Unit 3794 and has examined 217 patent applications in our dataset. With an allowance rate of 48.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.

Allowance Patterns

Examiner AVIGAN, ADAM JOSEPH's allowance rate of 48.8% places them in the 12% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by AVIGAN, ADAM JOSEPH receive 2.72 office actions before reaching final disposition. This places the examiner in the 76% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by AVIGAN, ADAM JOSEPH is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +3.9% benefit to allowance rate for applications examined by AVIGAN, ADAM JOSEPH. This interview benefit is in the 28% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 12.5% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.9% of cases where such amendments are filed. This entry rate is in the 24% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 36.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 36% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 52.4% of appeals filed. This is in the 24% percentile among all examiners. Of these withdrawals, 36.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 48.5% are granted (fully or in part). This grant rate is in the 42% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 53% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.